INmuneBIO Investors
INmuneBIO is a private equity firm based in La Jolla, California, founded in 2015 The firm specializes in investing in innovative biotechnology and pharmaceutical companies that are focused on developing novel therapies With a significant investment scale, INmuneBIO aims to drive advancements in immune-based treatments and enhance patient outcomes The firm leverages its expertise and strategic partnerships to identify and support promising opportunities in the healthcare sector
Employee Number:
11-50
Investors Number:
2
Funding Status:
IPO
Headquarters:
USA
Technology:
Data-driven Technologies
Estimated Revenue:
Less than $1M
Founded Date:
2015
Last Funding Type:
Post-IPO Equity
Investor Type:
Private Equity Firms
Total Funding:
$48.2M
Industry:
FemTech